Lai et al. [7] constructed a three DNA repair-related genes signature (RECQL, POLQ, and RAD17) to predict the prognosis of pancreatic cancer, and RAD17 expression is correlated with oxaliplatin treatment. The gene discussed is RAD17; the disease is pancreatic neoplasm.